Press release
UK Schizophrenia Drugs Market Size, Share, Growth, Research and Forecast 2020-2026
UK schizophrenia drug market is projected to grow at a significant CAGR of around 2.7% during the forecast period (2020-2026). UK has a well-developed healthcare infrastructure with an established mental health facility. National Health Services (NHS) England spends $7.2 million per year on mental health services for ex-service personnel, in addition to the $12.7 billion spending on mental health for the general population, therefore, create significant market growth in the country. Thus, UK has a developed schizophrenia drug market, which is further expected to grow during the forecast period. According to Living with Schizophrenia, UK has almost a quarter of a million people living with schizophrenia.A full report of UK Schizophrenia Drugs Market is available at: https://www.omrglobal.com/industry-reports/uk-schizophrenia-drugs-market
Improved medications and government support towards the treatment of such mental illnesses will contribute to the schizophrenia drug market in UK. Around 10% of all illnesses in the country are represented by schizophrenia. The huge prevalence of schizophrenia in UK has arisen the governmental bodies for the establishment of advanced treatment facilities for mental health, which includes mental hospitals/institutes and pharmaceutical companies. Schizophrenia is a major illness. At any one time, about 220,000 people are being treated for schizophrenia in UK by the NHS, as per Living with Schizophrenia. Therefore, significant growth can be expected in the schizophrenia drug market in UK during the forecast period.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-schizophrenia-drugs-market
Market Coverage
• The market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segments Covered
o By Therapeutic Class
o By Treatment
• Allergan PLC, Catalent, Inc., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc.
Key questions addressed by the report
• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-schizophrenia-drugs-market
UK Schizophrenia Drugs Market – Segmentation
By Therapeutic Class
• Second Generation Antipsychotics
• Third Generation Antipsychotics
• Others (First Generation Antipsychotics)
By Treatment
• Oral
• Injectables
Company Profiles
• Alkermes PLC
• Allergan PLC
• AstraZeneca PLC
• Biogen Inc.
• Eli Lilly and Co.
• H. Lundbeck A/S
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck & Co., Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release UK Schizophrenia Drugs Market Size, Share, Growth, Research and Forecast 2020-2026 here
News-ID: 2139545 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Schizophrenia
Rising Mental Illness Burden Fuels Growth In The Schizophrenia Market: Pivotal F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Schizophrenia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the schizophrenia market size has seen robust growth. The projected growth from $5.82 billion in 2024 to $6.11 billion in 2025, signifies a compound annual growth rate (CAGR) of 5.0%. Factors such as increased…
Clozapine Market: Transforming the Treatment Landscape for Schizophrenia
Clozapine, an atypical antipsychotic medication, has emerged as a critical treatment option for patients with treatment-resistant schizophrenia and other severe psychiatric disorders. As one of the most effective therapies available for reducing symptoms in individuals who do not respond adequately to other antipsychotic medications, clozapine plays a vital role in modern psychiatry. This article provides a comprehensive overview of the clozapine market, exploring market information, key trends, challenges, and detailed…
Schizophrenia Drugs Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Schizophrenia Drugs Market was valued at USD 5.3 Billion in 2018 and is projected to reach USD 8.42 Billion by 2026, growing at a CAGR of 3.66% from 2019 to 2026.
Market Overview for Schizophrenia Drugs Market
Schizophrenia Drugs Market OverviewThe schizophrenia drugs market is experiencing significant growth driven by advancements in pharmacotherapy and increasing awareness about mental health disorders. Schizophrenia, a chronic and severe mental disorder affecting millions…
Schizophrenia Drugs Market - Restoring Balance, Inspiring Hope: Schizophrenia Dr …
Newark, New Castle, USA: The "Schizophrenia Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Schizophrenia Drugs Market: https://www.growthplusreports.com/report/schizophrenia-drugs-market/7871
This latest report researches the industry structure, sales, revenue,…
Schizophrenia Drugs Market - Leading the Way in Schizophrenia Treatment: Nurturi …
Newark, New Castle, USA - new report, titled Schizophrenia Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Schizophrenia Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Schizophrenia Drugs market. The report offers an overview of the market, which…
Schizophrenia Drug Market & Pipeline Insight
Schizophrenia is defined as a disorder of the brain which impacts the way in which a person acts, thinks, and sees the world. It has been observed that the patients suffering from schizophrenia generally tend to have an altered perception of reality, which reveals a significant diversion from the reality. In most cases, schizophrenia is diagnosed among people in the late teens or early adulthood. However, middle-aged people also could…